Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Epitope Dependent Augmentation of the Immune Response in Hemophilia Α Mice Immunized with Factor VIII/Antibody Immune Complexes

Glaivy Batsuli, MD, Seema R Patel, PhD, Courtney Cox, MSc, Wallace H. Baldwin, John S. Lollar, MD, Shannon L. Meeks, MD

Blood (2019) 134 (Supplement_1): 2387.

https://doi.org/10.1182/blood-2019-127436

Published: 2019

Journal Articles

The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia a

Seema R Patel, PhD, Wallace H. Baldwin, Courtney Cox, MSc, John Healey, BS, Ernest T. Parker, Glaivy Batsuli, MD, Shannon L. Meeks, MD

Blood (2019) 134 (Supplement_1): 1109.

https://doi.org/10.1182/blood-2019-130890

Published: 2019

Journal Articles

Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A

Patricia E. Zerra, Courtney Cox, W. Hunter Baldwin, Seema R. Patel, Connie M. Arthur, Pete Lollar, Shannon L. Meeks, Sean R. Stowell

Blood (2017) 130 (23): 2559–2568.

https://doi.org/10.1182/blood-2017-05-782912

Published: 2017

Includes: Supplemental data

Journal Articles

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

Shannon L. Meeks, MD, Courtney Cox, MSc, W. Hunter Baldwin, BS

Blood (2017) 130 (Supplement 1): 2364.

https://doi.org/10.1182/blood.V130.Suppl_1.2364.2364

Published: 2017

Journal Articles

The Impact of Anti-Factor VIII A1 and A3 Domain Antibodies in the Immune Reponse to Factor VIII in Patients with Hemophilia a

Jasmine C Ito, Courtney Cox, MSc, W. Hunter Baldwin, BS, Christopher B Doering, PhD, Shannon L. Meeks, MD

Blood (2017) 130 (Supplement 1): 2373.

https://doi.org/10.1182/blood.V130.Suppl_1.2373.2373

Published: 2017

Journal Articles

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

Glaivy Batsuli, MD, Wallace Hunter Baldwin, BS, John F Healey, BS, Ernest T Parker, BS, Courtney Cox, MSc, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2016) 128 (22): 3762.

https://doi.org/10.1182/blood.V128.22.3762.3762

Published: 2016

Journal Articles

High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors

Glaivy Batsuli, Wei Deng, John F. Healey, Ernest T. Parker, W. Hunter Baldwin, Courtney Cox, Brenda Nguyen, Joerg Kahle, Christoph Königs, Renhao Li, Pete Lollar, Shannon L. Meeks

Blood (2016) 128 (16): 2055–2067.

https://doi.org/10.1182/blood-2016-02-701805

Published: 2016

Includes: Supplemental data

Journal Articles

A subset of high-titer anti–factor VIII A2 domain antibodies is responsive to treatment with factor VIII

Joshua Eubanks, W. Hunter Baldwin, Rebecca Markovitz, Ernest T. Parker, Courtney Cox, Christine L. Kempton, Shannon L. Meeks

Blood (2016) 127 (16): 2028–2034.

https://doi.org/10.1182/blood-2015-09-670034

Published: 2016

Journal Articles

B-Cell Epitope Mapping of Severe Hemophilia a Plasma Using Well Characterized Murine Anti-Factor VIII Monoclonal Antibodies

Shannon Meeks, MD, W. Hunter Baldwin, BS, Courtney Cox, MS

Blood (2015) 126 (23): 1084.

https://doi.org/10.1182/blood.V126.23.1084.1084

Published: 2015

Journal Articles

Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers

Glaivy Batsuli, MD, John Healey, BS, Ernest Parker, BS, Wallace Hunter Baldwin, BS, Courtney Cox, MSc, Brenda Nguyen, BS, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2015) 126 (23): 1066.

https://doi.org/10.1182/blood.V126.23.1066.1066

Published: 2015

Journal Articles

Marginal Zone B Cell Depletion Prevents Factor VIII Inhibitor Development in Model of Hemophilia

Courtney Cox, MS, Patricia Zerra, MD, Connie Authur, PhD, Seema Patel, PhD, Shannon Meeks, MD, Sean R. Stowell, MD PhD

Blood (2015) 126 (23): 1068.

https://doi.org/10.1182/blood.V126.23.1068.1068

Published: 2015

Journal Articles

The Diversity of Anti-Factor VIII B-Cell Epitopes in Hemophilia a Patients with Inhibitors

Margaret A. Robinson, B.A., Courtney Cox, M.S., Wallace Hunter Baldwin, Philip Zakas, Shannon L Meeks, MD

Blood (2014) 124 (21): 2837.

https://doi.org/10.1182/blood.V124.21.2837.2837

Published: 2014

Journal Articles

Beyond the Bethesda Assay- Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles

Tami Livnat, PhD, Amy Dunn, Shirley Azar- Avivi, Courtney Cox, Einat Avishai, Shannon L. Meeks, MD, Gili Kenet, MD

Blood (2014) 124 (21): 2841.

https://doi.org/10.1182/blood.V124.21.2841.2841

Published: 2014

Journal Articles

Anti-Factor VIII C1 Domain Antibodies Are Present in the Plasmas of Patients with Hemophilia and Inhibitors

Glaivy Batsuli, MD, Courtney Cox, M.S., John F. Healey, B.S., Pete Lollar, MD, Shannon L Meeks, MD

Blood (2014) 124 (21): 1482.

https://doi.org/10.1182/blood.V124.21.1482.1482

Published: 2014

Journal Articles

Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas

Bhavya Doshi, Courtney Cox, M.S., Bagirath Gangadharan, MS, Christopher B Doering, PhD, Shannon L. Meeks, MD

Blood (2011) 118 (21): 28.

https://doi.org/10.1182/blood.V118.21.28.28

Published: 2011

Journal Articles

Factor VIII Structure, Not Activity, Is the Primary Determinant of Immunogenicity in Hemophilia A and Combined Hemophilia A/Von Willebrand Disease Mice

Shannon L. Meeks, MD, Courtney Cox, M.S., John F. Healey, B.S., Ernest T Parker, B.A., Bagirath Gangadharan, MS, Rachel T. Barrow, BS, John (Pete) S. Lollar, III, M.D.

Blood (2011) 118 (21): 1187.

https://doi.org/10.1182/blood.V118.21.1187.1187

Published: 2011

NARROW

Epitope Dependent Augmentation of the Immune Response in Hemophilia Α Mice Immunized with Factor VIII/Antibody Immune Complexes

The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia a

Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

The Impact of Anti-Factor VIII A1 and A3 Domain Antibodies in the Immune Reponse to Factor VIII in Patients with Hemophilia a

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors

A subset of high-titer anti–factor VIII A2 domain antibodies is responsive to treatment with factor VIII

B-Cell Epitope Mapping of Severe Hemophilia a Plasma Using Well Characterized Murine Anti-Factor VIII Monoclonal Antibodies

Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers

Marginal Zone B Cell Depletion Prevents Factor VIII Inhibitor Development in Model of Hemophilia

The Diversity of Anti-Factor VIII B-Cell Epitopes in Hemophilia a Patients with Inhibitors

Beyond the Bethesda Assay- Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles

Anti-Factor VIII C1 Domain Antibodies Are Present in the Plasmas of Patients with Hemophilia and Inhibitors

Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas

Factor VIII Structure, Not Activity, Is the Primary Determinant of Immunogenicity in Hemophilia A and Combined Hemophilia A/Von Willebrand Disease Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only